Birth Defect Drugs
June 2, 2011
A study shows newer anti-epileptic drugs (some of which are used off label to treat migraine headaches) are not associated with birth defects when taken in first trimester of pregnancy.
Topics:
Health Medical Pharma, Obstetrics, Headaches, neurological disorders, migraine headaches, Human Interest, Cluster headache, valproic acid, epilepsy, Holoprosencephaly, Off-label use, Pregnancy, Migraine